- 101. Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334846) Myeloblasts Under 10% of Bone Marrow Nucleated Cells;
=Laboratory or Test Result | - 151. Myofibroblast
- [A spindle-shaped cell that exhibits characteristics of both fibroblasts and smooth muscle cells. It has an elongated nucleus and does not have basal lamina. The cytoplasm can be distinguished from the surrounding matrix because of actin filaments, myosin and other muscle proteins arranged to suggest a contractile ability. ( NCI )] (UMLS (NCI) C0225360) =Cell
|
- 102. Myeloblasts Under 2 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334850) Myeloblasts Under 2% of Peripheral Blood White Cells =Laboratory or Test Result
| - 152. Myofibroblastoma
- [A benign, well circumscribed soft tissue neoplasm characterized by the presence of spindle shaped myofibroblasts and mast cells in a collagenous stroma. ( NCI )] (UMLS (NCI) C0242404) =Neoplastic Process ;
|
- 103. Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334848) Myeloblasts Under 20% of Bone Marrow Nucleated Cells =Laboratory or Test Result
| - 153. Myofibroma
- [A benign localized neoplasm arising from the subcutaneous tissues and skeletal muscle. It is characterized by the presence of myofibroblastic hyperchromatic spindle cells, hylanized stroma formation, calcification, necrosis, and a multinodular growth pattern. ( NCI )] (UMLS (NCI) C1368237) Solitary Myofibromatosis =Neoplastic Process
|
- 104. Myeloblasts Under 20 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334849) Myeloblasts Under 20% of Peripheral Blood White Cells =Laboratory or Test Result
| - 154. myogenesis
- [development of muscle tissue. ( CSP )] (UMLS (CSP) C0596997) =Organ or Tissue Function =Developmental Process, Multicellular;
=myotube;
|
- 105. Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells
- (UMLS (NCI) C1334851) Myeloblasts Under 5% of Bone Marrow Nucleated Cells =Laboratory or Test Result
| - 155. MYOGENIC PTOSIS
- [ ] (UMLS (ICD9CM) C0155201) =Pathologic Function
|
- 106. Myeloblasts Under 5 Percent of Peripheral Blood White Cells
- (UMLS (NCI) C1334852) Myeloblasts Under 5% of Peripheral Blood White Cells =Laboratory or Test Result
| - 156. myoglobin
- [conjugated protein which is the oxygen-transporting pigment of muscle, made up of one globin polypeptide chain and one heme group. ( CSP )] (UMLS (CSP) C0027078) =Amino Acid, Peptide, or Protein; Biologically Active Substance =globin;
heme protein;
muscle protein;
|
- 107. Myelobromol
- (UMLS (NCI) C0700014) =Carbohydrate; Pharmacologic Substance ;
| - 157. MYOGLOBINURIA
- (UMLS (ICD9CM) C0027080) =Finding ;
=RHABDOMYOLYSIS;
|
- 108. myelocyte
- [precursor in the granulocytic series; in this stage, differentiation into specific cytoplasmic granules has begun. ( CSP )] (UMLS (CSP) C0369715) =Cell ;
=Granulocyte;
| - 158. Myoid Dermatofibrosarcoma Protuberans
- [A morphologic variant of dermatofibrosarcoma protuberans characterized by the presence of areas of myofibroblastic differentiation. ( NCI )] (UMLS (NCI) C1334853) =Neoplastic Process
|
- 109. Myelocytic Leukemia in Remission
- [Granulocytic leukemia, remission. 1. Abatement or lessening in severity of the symptoms of a disease. 2. The period during which such abatement occurs. ( NCI )] (UMLS (NCI) C0686593) =Neoplastic Process
| - 159. Myomectomy
- [Surgical removal of part of the uterine body, frequently performed as a treatment for leiomyomas. ( NCI )] (UMLS (NCI) C0195309) =Therapeutic or Preventive Procedure
|
- 110. myelodysplastic anemia
- [ ] (UMLS (CSP) C0598338) =Disease or Syndrome
| - 160. Myometrial
- [Of or pertaining to the myometrium. ( NCI )] (UMLS (NCI) C0521387) =Body Location or Region
|
- 111. Myelodysplastic syndrome with 5q deletion
- [ ] (UMLS (ICD9CM) C1719311) MYELODYSPLS SYN W 5Q DEL =Disease or Syndrome
| - 161. Myometrium
- [smooth muscle coat of the uterus, which forms the mass of the organ. ( CSP )] (UMLS (NCI) C0027088) =Body Part, Organ, or Organ Component ;
=Genital System, Female, Uterus;
Smooth Muscle |
- 112. myelogenous
- [(mye-eh-LAH-jen-us) Produced by, or originating in, the bone marrow. ( NCI )] (UMLS (NCI) C0439677) =Qualitative Concept
| - 162. myoneural disorder
- [diseases affecting the parts of motor units that are in the peripheral nervous system; can be classified as affecting neuromuscular junctions, and muscle fibers. ( CSP )] (UMLS (CSP) C0027868) =Disease or Syndrome ;
=muscle disorder;
CNS DISORDER NOS;
DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM;
=myasthenia gravis;
ATSEDENIK GABEKO ZANGOEN SINDROMEA;
muscle disorder;
DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM;
degenerative motor system disease;
stiff man syndrome;
Neuromuscular Junction Diseases;
|
- 113. Myelogram
- (UMLS (HL7) C1548886) =Health Care Activity =Consent Type;
| - 163. MYONEURAL DISORDERS NEC
- [ ] (UMLS (ICD9CM) C0029816) =Disease or Syndrome
|
- 114. Myeloid Cell
- [Cells which include the monocytes and the granulocytes. (MeSH) ( NCI )] (UMLS (NCI) C0887899) Myeloid Cells =Cell ;
| - 164. myoneural junction
- [synapse between a neuron and a muscle. ( CSP )] (UMLS (CSP) C0027869) =Cell Component ;
=synapse;
|
- 115. Myeloid sarcoma without mention of remission
- (UMLS (ICD9CM) C0153891) =Neoplastic Process
| - 165. MYOPATHIES NEC
- (UMLS (ICD9CM) C0546839) =Disease or Syndrome ;
|
- 116. Myeloleukon
- (UMLS (NCI) C0728928) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 166. MYOPATHY IN ENDOCRIN DIS
- (UMLS (ICD9CM) C0154770) =Disease or Syndrome ;
|
- 117. myeloma and spleen cell hybrid
- [ ] (UMLS (CSP) C0598625) =Cell ;
| - 167. Myopericytoma
- [A usually slow growing, subcutaneous nodular neoplasm arising from myopericytes. It is composed of myoid cells arranged in a perivascular growth pattern. The vast majority of cases have a benign clinical course. ( NCI )] (UMLS (NCI) C1302808) =Neoplastic Process
|
- 118. myeloma globulin
- [abnormal globulins with unusual thermosolubility characteristics that are found in the urine of patients with multiple myeloma. ( CSP )] (UMLS (CSP) C0178753) =Amino Acid, Peptide, or Protein; Biologically Active Substance =globulin;
| - 168. myopia
- [a refractive error in which rays of light entering the eye parallel to the optic axis are brought to a focus in front of the retina, as a result of the eyeball being too long from front to back; also called nearsightedness because the near point is less distant than it is in emmetropia with an equal amplitude of accommodation. ( CSP )] (UMLS (CSP) C0027092) =Disease or Syndrome ;
=Alteraciones de la refraccion;
|
- 119. MYELOMENINGOCEL REPAIR
- [ ] (UMLS (ICD9CM) C0196477) =Therapeutic or Preventive Procedure
| - 169. myosin
- [superfamily of proteins that function as translocating proteins the common characteristics are to bind actin and hydrolyze MgATP generally consist of heavy chains which are involved in locomotion, and light chains which are are involved in regulation superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. ( CSP )] (UMLS (CSP) C0027096) =Amino Acid, Peptide, or Protein; Enzyme =ABP;
Adenosine Triphosphatase;
muscle protein;
|
- 120. myelopathy
- [pathologic conditions which feature spinal cord damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. ( CSP )] (UMLS (CSP) C0037928) =Disease or Syndrome ;
=Central Nervous System Disease;
=amyotonia congenita;
ALS;
Injury, spinal cord;
PROG MUSCULAR ATROPHY;
ALS;
Muscular Atrophy, Spinal;
myelitis;
Injury, spinal cord;
Neoplasm of Spinal Cord;
Spinocerebellar Degenerations;
syringomyelia;
Tabes dorsalis;
stiff man syndrome;
Epidural Abscess;
Spinal Cord Vascular Diseases | - 170. myositis
- [inflammation of skeletal muscle. ( CSP )] (UMLS (CSP) C0027121) =Disease or Syndrome ;
=muscle disorder;
=Fibrodysplasia Ossificans Progressiva;
polymyositis;
Myositis Ossificans;
polymyositis;
inclusion body myositis;
|
- 121. MYELOPATHY IN OTH DIS
- (UMLS (ICD9CM) C0154687) =Disease or Syndrome ;
| - 171. Myositis Ossificans
- [A disease characterized by bony deposits or the ossification of muscle tissue. ( MSH )] (UMLS (NCI) C0027122) =Disease or Syndrome ;
=myositis;
|
- 122. MYELOPATHY NEC
- [ ] (UMLS (ICD9CM) C1961841) Other myelopathy;
=Disease or Syndrome ;
| - 172. myostatin
- [member of TGF beta superfamily. ( CSP )] (UMLS (CSP) C1457899) =Amino Acid, Peptide, or Protein; Biologically Active Substance =TGF;
|
- 123. myeloperoxidase
- [A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. ( MSH )] (UMLS (CSP) C0027021) =Amino Acid, Peptide, or Protein; Enzyme ;
=peroxidase;
| - 173. Myostibin
- (UMLS (NCI) C0878129) =Organic Chemical; Pharmacologic Substance
|
- 124. MYELOPHTHISIS
- (UMLS (ICD9CM) C0302112) =Cell or Molecular Dysfunction ;
| - 174. MYOTOMY
- [ ] (UMLS (ICD9CM) C0185181) =Therapeutic or Preventive Procedure
|
- 125. Myelopoiesis
- [The formation of non-leukoid differentiated blood cells (NCI) ( NCI )] (UMLS (NCI) C0525006) =Organ or Tissue Function ;
| - 175. MYOTOMY OF COLON NEC
- [ ] (UMLS (ICD9CM) C0176827) =Therapeutic or Preventive Procedure
|
- 126. Myelosan
- (UMLS (NCI) C0728926) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 176. MYOTOMY OF HAND
- [ ] (UMLS (ICD9CM) C0187120) =Therapeutic or Preventive Procedure
|
- 127. myelosuppression
- [A condition in which bone marrow activity is decreased, resulting in fewer red blood cells, white blood cells, and platelets. Myelosuppression is a side effect of some cancer treatments. ( NCI )] (UMLS (NCI) C0854467) =Disease or Syndrome
| - 177. MYOTOMY OF SIGMOID COLON
- [ ] (UMLS (ICD9CM) C0176826) =Therapeutic or Preventive Procedure
|
- 128. MYH11
- [This gene plays a regulatory role in muscle contraction and the required ATP hydrolysis. ( NCI )] (UMLS (NCI) C1334538) MYH11 Gene;
Myosin, Heavy Polypeptide 11, Smooth Muscle Gene =Gene or Genome | - 178. myotonia atrophica
- [autosomal dominant neuromuscular disorder which usually presents in early adulthood, characterized by progressive muscular atrophy (most frequently involving the hands, forearms, and face), myotonia, frontal baldness, lenticular opacities, and testicular atrophy; cardiac conduction abnormalities, diaphragmatic weakness, and mild mental retardation may also occur; congenital myotonic dystrophy is a severe form of this disorder. ( CSP )] (UMLS (CSP) C0027126) =Disease or Syndrome ;
=HERED PROG MUSC DYSTRPHY;
Myotonic disorders;
congenital neuromuscular disorder;
|
- 129. MYH11
- [Smooth Muscle Myosin Heavy Chain 11, encoded by the human MYH11 gene belonging to the myosin heavy chain family. This protein is a subunit of a hexameric protein that consists of two heavy chain subunits and two pairs of non-identical light chain subunits. It functions as a major contractile protein, converting chemical energy into mechanical energy through the hydrolysis of ATP. The pericentric inversion of chromosome 16 produces a protein consisting of the first 165 residues from the N terminus of core-binding factor beta in a fusion with the C-terminal portion of the smooth muscle myosin heavy chain. This chromosomal rearrangement is associated with acute myeloid leukemia of the M4Eo subtype. Alternative splicing generates isoforms that are differentially expressed, with ratios changing during muscle cell maturation. Additional splice variants exist. (from LocusLink) ( NCI )] (UMLS (NCI) C1336017) Myosin Heavy Chain, Smooth Muscle Isoform;
Myosin, Heavy Polypeptide 11, Smooth Muscle;
Myosin, Smooth Muscle, Heavy Chain 11;
SMHC;
SMMHC;
Smooth Muscle Myosin Heavy Chain 11 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 179. myotonia congenita
- [congenital genetic disease characterized by tonic spasm and rigidity of certain muscles when a voluntary movement is attempted; also known as Thomsen's disease. ( CSP )] (UMLS (CSP) C0027127) =Disease or Syndrome ;
=Genetic Condition;
Myotonic disorders;
congenital neuromuscular disorder;
Heredodegenerative Disorders, Nervous System |
- 130. MYIASIS
- [The invasion of living tissues of man and other mammals by dipterous larvae. ( MSH )] (UMLS (ICD9CM) C0027030) =Disease or Syndrome =Ectoparasitic Infestations;
=Hypodermyiasis;
Screw Worm Infection | - 180. MYOTONIC CATARACT
- (UMLS (ICD9CM) C0027128) =Acquired Abnormality; Disease or Syndrome
|
- 131. Mylanta
- [A commercial combination preparation, by Johnson & Johnson-Merck Consumer Pharmaceuticals, containing the antacids aluminum hydroxide and magnesium hydroxide. Aluminum hydroxide and magnesium hydroxide neutralize stomach acids, thereby raising the pH to reduce intestinal damage by acids. ( NCI )] (UMLS (NCI) C0067044) =Pharmacologic Substance
| - 181. Myotonic chondrodystrophy
- (UMLS (ICD9CM) C0036391) =Congenital Abnormality; Disease or Syndrome
|
- 132. Mylecytan
- (UMLS (NCI) C0728927) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 182. MYOTONIC DISORDER NEC
- [ ] (UMLS (ICD9CM) C1955767) Other specified myotonic disorder;
=Disease or Syndrome |
- 133. Myleran
- (UMLS (NCI) C0700015) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 183. Myotonic disorders
- [Diseases characterized by MYOTONIA, which may be inherited or acquired. Myotonia may be restricted to certain muscles (e.g., intrinsic hand muscles) or occur as a generalized condition. These disorders may be associated with abnormal muscle SODIUM CHANNEL and CHLORIDE CHANNELS. MYOTONIC DYSTROPHY and MYOTONIA CONGENITA represent two relatively common forms of this disorder. Proximal myotonic myopathy often presents with myotonia and muscle pain in early adulthood and later in life thigh muscle weakness and cataracts develop. (From Adams et al., Principles of Neurology, 6th ed, p1392) ( MSH )] (UMLS (ICD9CM) C0553604) =Disease or Syndrome =muscle disorder;
=myotonia atrophica;
myotonia congenita;
|
- 134. MYLK
- [This gene plays a role in smooth muscle contraction. ( NCI )] (UMLS (NCI) C1334539) MYLK Gene;
Myosin, Light Polypeptide Kinase Gene =Gene or Genome | - 184. MYOTONIC MUSCLR DYSTRPHY
- (UMLS (ICD9CM) C0242007) =Disease or Syndrome
|
- 135. Mylohyoid
- (UMLS (NCI) C0224159) =Body Part, Organ, or Organ Component
| - 185. myotube
- [developing muscle fiber in which the nucleus is still located centrally, before moving to the periphery of the cell. ( CSP )] (UMLS (CSP) C0242697) =Cell ;
=myogenesis;
|
- 136. Myoblast
- [precursor cells of the myogenic lineage that develop from the mesoderm; undergo proliferation, migrate to their various sites, and then differentiate into the appropriate form of myocytes. ( CSP )] (UMLS (NCI) C0596995) =Cell =Muscle Cell;
| - 186. Myoviridae
- [A family of BACTERIOPHAGES and ARCHAEAL VIRUSES which are characterized by complex contractile tails. ( MSH )] (UMLS (CSP) C0206378) =Virus
|
- 137. MYOCARDIAL DEGENERATION
- (UMLS (ICD9CM) C0027046) =Pathologic Function
| - 187. Myprozine
- (UMLS (NCI) C0699516) =Organic Chemical; Antibiotic
|
- 138. myocardial depressant
- [ ] (UMLS (CSP) C0027048) =Pharmacologic Substance
| - 188. Myriapoda
- [ ] (UMLS (CSP) C0597910) =Invertebrate ;
|
- 139. myocardial hypoxia
- [ ] (UMLS (CSP) C0920715) =Disease or Syndrome ;
| - 189. myringoplasty
- [Surgical restoration of a perforated tympanic membrane by grafting. (Dorland, 28th ed.) ( MSH )] (UMLS (CSP) C0027136) =Therapeutic or Preventive Procedure ;
|
- 140. myocardial infarct sizing
- [methods of measuring extent of myocardial infarcts. ( CSP )] (UMLS (CSP) C0596996) =Diagnostic Procedure =heart disorder diagnosis;
| - 190. Myringotomy
- (UMLS (ICD9CM) C0087123) =Therapeutic or Preventive Procedure
|
- 141. Myocardial Neoplasm
- (UMLS (NCI) C1290402) Myocardial Tumor;
Neoplasm of Myocardium;
Neoplasm of the Myocardium;
Tumor of Myocardium;
Tumor of the Myocardium =Neoplastic Process ;
| - 191. MYRINGOTOMY NEC
- [ ] (UMLS (ICD9CM) C0176334) =Therapeutic or Preventive Procedure
|
- 142. myocarditis
- [inflammation of the muscular walls of the heart. ( CSP )] (UMLS (CSP) C0027059) =Disease or Syndrome =cardiomyopathy;
| - 192. MYRINGOTOMY W INTUBATION
- [ ] (UMLS (ICD9CM) C1970956) Myringotomy with insertion of tube;
=Therapeutic or Preventive Procedure |
- 143. Myocarditis due to toxoplasmosis
- [ ] (UMLS (ICD9CM) C0276804) =Disease or Syndrome
| - 193. myristate
- [14 carbon straight chain saturated fatty acid common in membrane phospholipids and fatty acylated proteins. ( CSP )] (UMLS (CSP) C0129533) =Lipid; Biologically Active Substance ;
=long chain fatty acid;
saturated fatty acid |
- 144. myocardosis
- [ ] (UMLS (CSP) C0541731) =Disease or Syndrome ;
| - 194. myristoylation
- [ ] (UMLS (CSP) C0598434) =Molecular Function ;
|
- 145. Myocastor
- [ ] (UMLS (CSP) C1271110) =Mammal
| - 195. Myrmecia
- [ ] (UMLS (CSP) C0343651) =Disease or Syndrome
|
- 146. myocilin
- [encodes a trabecular meshwork protein; causes primary open angle glaucoma. ( CSP )] (UMLS (CSP) C0534578) =Amino Acid, Peptide, or Protein; Biologically Active Substance =cytoskeletal protein;
| - 196. Myrrh
- (UMLS (NCI) C0207011) =Organic Chemical; Pharmacologic Substance ;
=MYRRH MISC. OIL;
Inactive Ingredient Preparations =AMYL METACRESOL/BENZOCAINE/MYRRH/PHENOL/ALCOHOL 70% SOLN;
MYRRH MISC. TINCTURE |
- 147. Myoclonic Jerk
- [shock-like contraction of a portion of a muscle, an entire muscle, or a group of muscles; may be part of a disease process or a normal physiological response. ( CSP )] (UMLS (NCI) C0027066) =Sign or Symptom =Dyscinesia;
extrapyramidal disorder;
muscle disorder;
| - 197. Mytilus
- [A genus of marine mussels in the family MYTILIDAE, class BIVALVIA. The species MYTILUS EDULIS is the highly edible common mussel. ( MSH )] (UMLS (CSP) C0027144) =Invertebrate ;
|
- 148. Myoepithelial Neoplasm
- [A usually benign tumor made up predominantly of myoepithelial cells. ( MSH )] (UMLS (NCI) C0027070) =Neoplastic Process =Neoplasms, Complex and Mixed;
| - 198. myxedema
- [condition characterized by a dry, waxy type of swelling with abnormal deposits of mucin in the skin and other tissues; it is produced by a functional insufficiency of the thyroid gland, resulting in deficiency of thyroid hormone. ( CSP )] (UMLS (CSP) C0027145) =Disease or Syndrome ;
=hypothyroidism;
Mucinoses |
- 149. Myoepithelium-Derived Serine Protease Inhibitor
- [Expressed in pancreas and adipose tissues by human SERPINI2 Gene (PAI-1 Serpin Family), 405-aa 46-kDa (precursor) secreted Protease Inhibitor 14 contains a signal peptide, 3 cysteine residues, and 3 potential N-glycosylation sites. SERPINI2 may have a role in a growth-control, possibly growth-suppression. (NCI) ( NCI )] (UMLS (NCI) C0675998) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 199. myxedematous infantilism
- [ ] (UMLS (CSP) C0598241) =Congenital Abnormality; Disease or Syndrome
|
- 150. myofibril
- [highly organized bundles of actin, myosins, and other proteins in the cytoplasm of skeletal and cardiac muscle cells that contract by a sliding filament mechanism; they are composed of numerous myofilaments. ( CSP )] (UMLS (CSP) C0027075) =Cell Component ;
=cell component;
| - 200. Myxicola
- [ ] (UMLS (CSP) C0027146) =Invertebrate ;
|
home
